 Predictive Value of Tests
"Predictive Value of Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
| Descriptor ID |
D011237
|
| MeSH Number(s) |
E05.318.780.800.650 N05.715.360.780.700.640 N06.850.520.445.800.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Predictive Value of Tests".
Below are MeSH descriptors whose meaning is more specific than "Predictive Value of Tests".
This graph shows the total number of publications written about "Predictive Value of Tests" by people in this website by year, and whether "Predictive Value of Tests" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 8 | 8 | | 1997 | 0 | 11 | 11 | | 1998 | 0 | 12 | 12 | | 1999 | 0 | 12 | 12 | | 2000 | 0 | 16 | 16 | | 2001 | 0 | 19 | 19 | | 2002 | 0 | 27 | 27 | | 2003 | 0 | 32 | 32 | | 2004 | 1 | 38 | 39 | | 2005 | 1 | 38 | 39 | | 2006 | 1 | 50 | 51 | | 2007 | 1 | 50 | 51 | | 2008 | 1 | 67 | 68 | | 2009 | 1 | 64 | 65 | | 2010 | 1 | 74 | 75 | | 2011 | 0 | 73 | 73 | | 2012 | 0 | 70 | 70 | | 2013 | 0 | 80 | 80 | | 2014 | 1 | 78 | 79 | | 2015 | 0 | 98 | 98 | | 2016 | 2 | 72 | 74 | | 2017 | 2 | 66 | 68 | | 2018 | 0 | 78 | 78 | | 2019 | 0 | 73 | 73 | | 2020 | 1 | 67 | 68 | | 2021 | 1 | 55 | 56 | | 2022 | 1 | 27 | 28 | | 2023 | 0 | 18 | 18 | | 2024 | 8 | 37 | 45 | | 2025 | 0 | 57 | 57 | | 2026 | 0 | 9 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Predictive Value of Tests" by people in Profiles.
-
Bakradze E, Shu L, Yaghi S, Tran TLN, Crandal RC, Lester E, Mandel DM, Siegler JE, Penckofer M, Liberman AL, Field TS, Khan F, Kam W, Mac Grory B, Saleh Velez FG, Henninger N, Elangovan C, Krishnaiah B, Gandhi P, Shahripour RB, Ghannam M, Heldner MR, Antonenko K, Rothstein A, Leker RR, Metanis I, Samaniego E, Romoli M, Zedde M, Pascarella R, Nguyen TN, Klein P, Khasiyev F, Khazaal O, Almajali M, Zubair AS, Elnazeir M, Marto JP, Nehme A, Giles JA, Engelter ST, Stretz C, Salehi Omran S. Possible Diagnostic Error in Cervical Artery Dissection: Analysis of STOP-CAD Study. J Am Heart Assoc. 2026 05 19; 15(10):e046408.
-
Farid M, Wang J, Perdikis B, Blasdel N, Darko K, O'Leary S, Barrie U, Khan H, Aoun SG. Assessing the Assessors: Comparative performance of frailty and nutritional metrics in predicting 30-Day morbidity and mortality after cranial neurosurgery. J Clin Neurosci. 2026 Aug; 150:112047.
-
Aksakal M, Chang D, Kharaji M, Watt C, Levitt MR, Hippe DS, Zhu C, Mossa-Basha M. Predicting Vasospasm and Delayed Cerebral Ischemia in Aneurysmal SAH: The Role of Vessel Wall MRI. AJNR Am J Neuroradiol. 2026 Apr 02; 47(4):937-943.
-
Shinde MU, Shapiro K, Hou L, Coughlin K, Madow AM, Shebl FM, Bright P, Pocobelli G, Ralston JD, Graham VF, Nolan MB, Binswanger IA, Pratt N, Hua W, Cocoros NM, Perez-Vilar S. Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness Studies. Pharmacoepidemiol Drug Saf. 2026 Apr; 35(4):e70363.
-
Goel K, Ormesher R, Pratte KA, Wang Y, Nishino K, Hersh CP, Kechris K, Bowler RP, Petrache I. Vascular-related proteomic signatures in COPD with suspected pulmonary hypertension as predictors of FEV1 impairment. Respir Res. 2026 Mar 28; 27(1).
-
Miles KG, Dorobantu DM, Douwes JM, Frank BS, Jone PN, Muthurangu V, Ivy DD, Nawaytou H, Friedberg MK. Current State of RV Multimodality Imaging in Pediatric Pulmonary Hypertension: Current Evidence, Knowledge Gaps, and Future Research Directions. Circ Cardiovasc Imaging. 2026 Mar; 19(3):e019264.
-
Oakland HT, Bellumkonda L, Sugeng L, Joseph P, Kundu P, Izzi D, Zalik F, McCabe S, Raza A, Amendola R, Heerdt PM, Hunter KS, Singh I. 3D echo derived right ventricular principal surface strain in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2026 Mar 01; 330(3):H729-H736.
-
Resch JE, Rosenblum DJ, McIndoe E, Donahue CC, Newman T, Thompson XD, Erdman NK, Walton SR, Pugh K, Broshek DK, Freeman J, MacKnight JM, Statuta SM, Barth JT. Leveraging the Enhanced Sports as a Laboratory Assessment Model to Cross-Validate a Formula Used to Predict Clinical Recovery From Concussion in Collegiate Athletes. J Athl Train. 2026 Jan; 61(1):89-101.
-
Basson DJ, Páez-Carpio A, Kalu A, Mughli RA, Du Plessis J, David E, Pugash R, Maroun G. Contralateral Suppression Index as a Surrogate Marker for Aldosterone Lateralization in Simulated Incomplete Adrenal Vein Sampling. J Vasc Interv Radiol. 2026 Apr; 37(4):107995.
-
Lindsey ML, Chen EI, Shivam P, Nde PN, Horn D, Renuse S, Hakimi A, Baxter BT, Terrin M, Matsumura JS, Gaye A, Curci JA. Comprehensive evaluation of plasma biomarkers in patients with abdominal aortic aneurysm using high-throughput, label-free quantitative proteomic profiling. Am J Physiol Heart Circ Physiol. 2026 02 01; 330(2):H000.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|